Cipher Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cipher Pharmaceuticals with three other
companies in this sector in Canada:
AEterna Zentaris Incorporated
sales of 34.93 million Canadian Dollars [US$26.19 million]
Acerus Pharmaceuticals Corporation
(24.34 million Canadian Dollars [US$18.25 million]
(22.83 million Canadian Dollars [US$17.11 million]
Cipher Pharmaceuticals reported sales of C$29.56 million (US$22.16 million)
December of 2018.
decrease of 43.4%
versus 2017, when the company's sales were C$52.22 million.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Cipher Pharmaceuticals had sales
of C$27.01 million.